Italian Breast Cancer Adjuvant Chemo-hormone Therapy Cooperative Group Trials
Authors:
- 1 January 1998
- book chapter
- Published by Springer Nature
- Vol. 152, 453-470
Abstract
The Adjuvant Chemo-hormone Therapy Breast Cancer Study Group (GROCTA) was formed exactly 15 years ago with its main purpose to promote co-operation among surgeons, clinical oncologists, clinical pathologists and basic researchers in the field of adjuvant therapy of breast cancer. This chapter will review the main findings from the trials that have been performed since then.Keywords
This publication has 24 references indexed in Scilit:
- 0-28. Adjuvant high dose chemotherapy (HD CT) without bone marrow rescue in breast cancer patients (b.c. pts) with 10 or more positive nodes (N ≥ 10): preliminary results of an Italian breast cancer adjuvant study group (GROCTA) trialThe Breast, 1997
- Lack of Effectiveness of Adjuvant Alternating Chemotherapy in Node-Positive, Estrogen-Receptor-Negative Premenopausal Breast Cancer Patients: Results of a Multicentric Italian StudyCancer Investigation, 1997
- Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast CancerJNCI: Journal of the National Cancer Institute, 1995
- ARIMIDEX™: A new oral, once-a-day aromatase inhibitorThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (breast cancer adjuvant chemo-hormone therapy cooperative group) trialEuropean Journal of Cancer, 1992
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI: Journal of the National Cancer Institute, 1990
- Primary medical therapy for operable breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Antiestrogen treatment of postmenopausal women with primary high risk breast cancerBreast Cancer Research and Treatment, 1983